Abstract:
The study involved 50 patients aged 54.5±4.4 years with knee osteoarthritis and who accounted for 43.8% of the X-ray 0 stage of the disease, Phase I-40% and Phase II-16.2%, which were allocated to the main and control groups. It is implemented that for reducing the amount of cartilage oligomer matrix protein (COMP) in the primary group applied treatment and traditional treatment for control group. According to the results obtained, the application of the proposed method in the knee joint osteoarthritis (OA) differs from the traditional method by a decrease in the amount of COMP in the serum (blood) of patients, it plays an important role in improving and maintaining the functional activity of the joints. In this,treatment aimed at the dynamics of COMP differs from the traditional method by the fact that the cartilage absorbs the stress of decomposition processes.
